- GST No. 27AAHFD2357G1ZI
- Send SMS
- Send Email
Twitter| Business Type | Manufacturer, Exporter |
| Name | Borviz Injection |
| Application | Borviz 2.5 Injection is used in the treatment of multiple myeloma and mantle-cell lymphoma. |
| MOQ | 5 |
| Click to view more | |
Preferred Buyer From
| Location | All Countries Except India |
Product Details
Port
Mumbai
Payment Terms
T/T, Western Union, MoneyGram
Delivery Time
5 - 7 working days
Packaging Details
Injection pack in bubble box.
The Borviz Injection is used for the treatment of multiple myeloma. With complete help and support of our team members, we deliver high grade and excellent range that commensurate to globally accepted standards. Thanks to our immense expertise of the domain, we as a Supplier, strives to deliver nothing short of excellence to our customers.
Details : Borviz contains Bortezomib which is the first therapeutic proteasome inhibitor to be tested in humans. It is approved in the U.S. for treating relapsed multiple myeloma and mantle cell lymphoma.
Specifications
| Brand Name | Borviz |
| Generic Name | Bortezomib |
| Company | Intas |
| Strength | 2mg |
| Packing | Vail |
| Type | Injection |
| Uses | Anticancer |
Looking for "Borviz Injection" ?
Bottle(s)
